CG Oncology Q3 EPS $(0.57) Misses $(0.56) Estimate, Sales $1.666M Beat $65.300K Estimate
Benzinga Newsdesk 11 months ago
EarningsEarnings BeatsEarnings MissesNews
CG Oncology (NASDAQ:CGON) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.56) by 1.24 percent. This is a 90 percent decrease over losses of $(0.30) per share from the
CG Oncology (NASDAQ:CGON) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.56) by 1.24 percent. This is a 90 percent decrease over losses of $(0.30) per share from the same period last year. The company reported quarterly sales of $1.666 million which beat the analyst consensus estimate of $65.300 thousand by 2.45K percent. This is a 3.77K percent increase over sales of $43.000 thousand the same period last year.